Tenon Medical, Inc. Announces 1:35 Reverse Stock Split

Tenon Medical (NASDAQ:TNON) has approved a 1-for-35 reverse stock split of its issued and outstanding common stock, effective at 12:01 a.m. Eastern Time on August 10, 2026.

Rhea-AI Summary

Tenon Medical (NASDAQ:TNON) has approved a 1-for-35 reverse stock split of its issued and outstanding common stock, effective at 12:01 a.m. Eastern Time on August 10, 2026. At that time, each 35 pre-split shares will be converted into one post-split share, and trading on the Nasdaq Capital Market will begin on a split-adjusted basis under the existing symbol “TNON” with a new CUSIP 88066N402.

The reverse split, authorized by stockholders on July 23, 2026, is intended to increase the per-share market price to meet Nasdaq’s $1.00 minimum average closing price requirement for continued listing. No fractional shares will be issued; any fractional amounts will be rounded up to the next whole share. Vstock Transfer will act as exchange agent, and most stockholders will not need to take action.

Positive

• 1-for-35 reverse stock split effective August 10, 2026 to support Nasdaq listing requirement
• No fractional shares issued; all fractional positions rounded up to the next whole share
• Shareholder approval obtained at July 23, 2026 annual meeting

Negative

• Company needed to address Nasdaq $1.00 minimum average closing price requirement for continued listing

News Explained

The material change is mechanical: the 1-for-35 reverse split reduces the number of common shares and proportionally raises the per-share price, while the split itself leaves company value unchanged.

Argus Aug 6 session 7 alerts

-12.41% close to close 1.5x rel. volume Open Argus

Details

Market move: TNON -12.41% in the Aug 6 session. 1:35 reverse stock split

+3.7% Peak Tracked

-4.1% Trough Tracked

$2.96M Market Cap

On Aug 6, the day this news came out, TNON closed 12.41% below the previous close. Argus tracked a peak move of +3.7% during that session. Argus tracked a trough of -4.1% from its starting point during tracking. Our momentum scanner recorded 7 alerts for this stock that day.

Data tracked by StockTitan Argus for the Aug 6 session.

Key Figures

Reverse split ratio: 1-for-35 Effective date: August 10, 2026 Share conversion: 35 shares +2 more

Reverse split ratio

1-for-35

Announced August 6, 2026

Effective date

August 10, 2026

Effective at 12:01 Eastern Time before Nasdaq trading

Share conversion

35 shares

Converted into one post-split share

Minimum closing price requirement

$1.00

Nasdaq Capital Market continued-listing requirement

Stockholder approval date

July 23, 2026

Reverse split approved at the annual meeting

Previous Stock split Reports

1 past event · Latest: Sep 04

Same Type 1 event

1. Sep 04

   Reverse stock split

   24h Move

   -8.7%

   1:8 reverse split targeted Nasdaq's $1.00 minimum average closing price requirement

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

reverse stock split, cusip number, exchange agent, book-entry shares

4 terms

reverse stock split financial

"today announced a 1-for-35 reverse stock split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

cusip number financial

"The new CUSIP number for the Company's common stock"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

exchange agent financial

"Vstock, the Company's transfer agent, is acting as the exchange agent"

An exchange agent is a third party appointed to handle the practical steps when securities are being swapped, such as during mergers, tender offers, or restructurings. Think of it as a trusted post office that collects old shares, verifies ownership, completes required paperwork and regulatory filings, and delivers the new shares or cash to investors; its efficiency and accuracy affect how quickly and safely investors receive the value they're owed.

book-entry shares financial

"Stockholders with book-entry shares or who hold their shares"

Shares recorded electronically on a central register or in brokerage accounts instead of being issued as paper certificates; ownership is shown as entries in a ledger much like a bank account record. This matters to investors because it makes buying, selling, dividend payments and voting simpler and faster, reduces the risk of lost certificates, and determines how ownership is tracked for corporate actions and legal rights.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOS GATOS, CA / ACCESS Newswire / August 6, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced a 1-for-35 reverse stock split of the Company's issued and outstanding common stock.

The reverse stock split will become effective at 12:01, Eastern Time, on August 10, 2026, prior to the commencement of trading on the Nasdaq Capital Market. As of that time, each 35 shares of issued and outstanding common stock will be converted into one share of common stock. The Company's common stock is expected to commence trading on a split-adjusted basis when the markets open on August 10, 2026, under the existing trading symbol "TNON." The new CUSIP number for the Company's common stock following the reverse stock split will be 88066N402.

At the annual meeting held on July 23, 2026, the Company's stockholders approved the reverse stock split. The primary goal of the reverse stock split is to increase the per share market price of the Company's common stock to meet the minimum $1.00 average closing price requirement for continued listing on the Nasdaq Capital Market.

Vstock Transfer, LLC ("Vstock"), the Company's transfer agent, is acting as the exchange agent for the reverse stock split. Stockholders with book-entry shares or who hold their shares through a bank, broker or other nominee will not need to take any action. Stockholders of record holding certificates representing pre-split shares of the Company's common stock, as applicable, will receive a letter of transmittal from Vstock with instructions on how to surrender certificates representing pre-split shares. Stockholders should not send in their pre-split certificates until they receive a letter of transmittal from Vstock. Unless a stockholder specifically requests a new paper certificate or holds restricted shares, stockholders of record who held pre-split certificates will receive their post-split shares book-entry and will be receiving a statement from Vstock regarding their common stock ownership post-reverse stock split. No fractional shares will be issued in connection with the reverse stock split. All fractional shares will be rounded up to the next whole share.

Additional information about the reverse stock split can be found in the Company's definitive proxy statement, as amended (the "Proxy Statement"), filed with the Securities and Exchange Commission (the "SEC") on June 23, 2026, which is available free of charge at the SEC's website, www.sec.gov, and on the Company's Investor Relations website at https://ir.tenonmed.com/.

About Tenon Medical, Inc.

Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran^™ SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all of the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+^® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.

For more information, please visit www.tenonmed.com. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.

The Tenon Medical logo shown above, and Catamaran^®, PiSIF^®, CAT PiSIF^®, ETAD^®, Posterior Inferior Sacroiliac Fusion^®, CAT SIJ Fusion System^®, Catamaran SIJ Fusion System^®, Catamaran Inferior Posterior Fusion System^®, Catamaran Transfixation Fusion System^®, Catamaran Transfixation Fusion Device^®, SImmetry^® are registered trademarks of Tenon Medical, Inc. MAINSAIL^TM, and SImmetry+ are also trademarks of Tenon Medical, Inc.

Safe Harbor

This press release contains "forward-looking statements," which are statements related to events, results, activities or developments that Tenon expects, believes or anticipates will or may occur in the future. Forward-looking statements often contain words such as "intends," "estimates," "anticipates," "hopes," "projects," "plans," "expects," "seek," "believes," "see," "should," "will," "would," "target," and similar expressions and the negative versions thereof. These forward-looking statements, include, but are not limited to, statements regarding the Company's ability to meet the minimum $1.00 average closing price requirement for continued listing on the Nasdaq Capital Market. Such statements are based on Tenon's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made. Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause Tenon's actual results to be materially different than those expressed in any of its forward-looking statements, please review Tenon's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and updated from time to time in our Form 10-Q filings and in our other public filings on file with the SEC at www.sec.gov, particularly the information contained in the section entitled "Risk Factors." We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.

IR Contact:

Shannon Devine
203-741-8811
MZ North America
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the ratio and effective date of Tenon Medical (TNON) reverse stock split?

Tenon Medical is implementing a 1-for-35 reverse stock split effective 12:01 a.m. Eastern Time on August 10, 2026. According to Tenon Medical, each 35 shares of common stock will automatically convert into one share at that time.

Why is Tenon Medical (TNON) doing a 1-for-35 reverse stock split in August 2026?

Tenon Medical is enacting the reverse stock split primarily to increase its per-share market price. According to Tenon Medical, the goal is to help meet Nasdaq’s $1.00 minimum average closing price requirement for continued listing on the Nasdaq Capital Market.

How will the Tenon Medical (TNON) reverse split affect existing shareholders?

Each shareholder’s 35 shares will be consolidated into one share, with proportional adjustment to share count. According to Tenon Medical, no fractional shares will be issued; any fractional share will be rounded up to the next whole share.

Do Tenon Medical (TNON) shareholders need to do anything for the reverse stock split?

Most shareholders will not need to take action because book-entry and broker-held shares adjust automatically. According to Tenon Medical, only holders of physical certificates will receive instructions from Vstock Transfer on surrendering pre-split certificates if needed.

When will Tenon Medical (TNON) start trading on a split-adjusted basis?

Tenon Medical common stock will begin trading on a split-adjusted basis when markets open on August 10, 2026. According to Tenon Medical, shares will continue under the symbol TNON with a new post-split CUSIP number 88066N402.

What happens to fractional shares in the Tenon Medical (TNON) reverse stock split?

No fractional Tenon Medical shares will be issued in the reverse split. According to Tenon Medical, any shareholder entitled to a fractional share will instead have that fraction rounded up to the next whole share of common stock.